Plasma KL-6 as a Potential Biomarker for Bronchopulmonary Dysplasia in Preterm Infants
Background. KL-6 is a biomarker of interstitial lung injury and increases during repair. Aim. Our aim was to determine the predictive value of plasma KL-6 for the development of bronchopulmonary dysplasia (BPD) in preterm infants. Methods. Ninety-five extremely preterm infants (EPIs), born at <28...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2024-01-01
|
Series: | Critical Care Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2024/3623948 |